ASAN FOUNDATION
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Strategy to Improve Adherence of Roflumilast
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT02018432
- Locations
- 🇰🇷
Department of Pulmonary and Critical Care Medicine and Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents
- Conditions
- Non-malignant DiseaseHaploidentical Hematopoietic Stem Cell TransplantationMalignant Disease
- Interventions
- Biological: anti-thymocyte globulinBiological: filgrastimRadiation: Total body irradiationProcedure: TCRαβ-depleted hematopoietic cell transplantationDevice: CliniMACS
- First Posted Date
- 2013-12-18
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT02014506
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Drug: FEC3-D3
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2017-08-29
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT02001506
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy
- Conditions
- Breast Cancer
- Interventions
- Drug: AC4-CDDP4
- First Posted Date
- 2013-12-05
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 88
- Registration Number
- NCT02001519
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
- Conditions
- Recurrent Breast CancerStage IV Breast Cancer
- Interventions
- Drug: [18F]fluoroestradiol (FES)
- First Posted Date
- 2013-11-18
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 93
- Registration Number
- NCT01986569
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
- Conditions
- Interstitial Cystitis
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 67
- Registration Number
- NCT01985880
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Asan medical center Institutional review board, Seoul, Korea, Republic of
Vaccination Status, Knowledge and Attitude in Korean Patients With IBD
- Conditions
- Inflammatory Bowel Disease
- Interventions
- Other: Survey with structured questionnaire form for inflammatory bowel disease patient group
- First Posted Date
- 2013-11-15
- Last Posted Date
- 2022-12-28
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 287
- Registration Number
- NCT01984879
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Micafungin Versus Fluconazole for Prevention of Invasive Fungal Disease in Living Donor Liver Transplant Recipients
- First Posted Date
- 2013-11-01
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 172
- Registration Number
- NCT01974375
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
- Conditions
- Central Serous Chorioretinopathy
- Interventions
- Drug: Sham injectionProcedure: Half-fluence photodynamic therapy
- First Posted Date
- 2013-10-29
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT01971190
- Locations
- 🇰🇷
Chungbuk national hospital, ChungJu, Korea, Republic of
🇰🇷Gangneung asan hospital, Gangneung, Korea, Republic of
🇰🇷Seoul national university Bundang Hospital, Ilsan, Korea, Republic of
[18F]Fluciclatide PET Imaging of Pazopanib Response
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2016-03-01
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT01961583
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of